and the SP has an 8% bounce.. I agree but yeah I'm not gonna be the one that says 'coulda, shoulda, woulda'
its biopharm sector, blowouts, overruns, missed timelines are part of the scenery
One thing that all of the above doesn't do is change the efficacy of the drug or the science behind it
Ann: Opthea Half Year Report and Accounts, page-3
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.0¢ |
Change
-0.005(0.76%) |
Mkt cap ! $800.2M | |||
| Open | High | Low | Value | Volume |
| 64.0¢ | 65.5¢ | 63.5¢ | $1.977M | 3.065M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13502 | 64.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.5¢ | 15085 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| OPT (ASX) Chart |